Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with ulcerative colitis (UC), Crohn's disease (CD), or a related condition called PSC-IBD for at least 6 months.
- People who are 18 years of age or older.
- People whose medical treatment for their bowel condition has remained the same for the past 3 months.
- People whose daily habits — including diet, exercise, and sleep — have stayed consistent over the past month.
- People who are willing and able to give their consent to participate, both verbally and in writing.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have taken antibiotics in the past 3 months.
- People who are currently pregnant or breastfeeding.
- People whose alcohol or substance use exceeds the limits set by the Danish Health Authority guidelines.
- People who have other known health conditions that may affect the gut microbiome, such as type 1 diabetes, other autoimmune diseases, cancer, or severe obesity (confirm with trial site for the full list of conditions considered).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sofie I Halkjær, PhD, Hvidovre University Hospital
Phone: +4538626199
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To characterize gut bacteriophages and bacteria in patients with IBD and in healthy controls (fecal donors), both as before and after fermentation in bioreactors
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.